E2F1 and angiosarcoma: This aligns with our findings, where younger dogs with hemangiosarcoma, whose tumors exhibited low expression of G2/M checkpoint transcripts, including E2F1, had significantly longer survival than older dogs with tumors expressing higher levels of these genes.